Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Low-temperature Labels

May 19, 2011 11:31 am | Product Releases | Comments

Computype, Inc. launched the Cryo Hold TS994, a label for plastic and glass labware made to withstand extreme conditions in the laboratory environment, that is suitable for flexographic imaging, thermal-transfer imaging, and automatic application.


Lilly Announces LY2127399 Data Presentation

May 19, 2011 11:23 am | News | Comments

Eli Lilly and Company announced Phase 1 data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.


MOR202 Data Shows Promising Results

May 19, 2011 11:19 am | News | Comments

MorphoSys AG announced promising pre-clinical data on MOR202 a fully human anti-CD38 antibody. By combining MOR202 with two approved drugs for the treatment of multiple myeloma, the anti-cancer activity of the antibody could be enhanced.


NJ Pushing Stricter Botox Law

May 19, 2011 11:12 am | by Josh Lederman | News | Comments

Minors in New Jersey won't be able to get Botox injections without a doctor saying it's medically necessary under a bill moving through the Assembly.


FBI Investigating 1982 Tylenol Deaths

May 19, 2011 11:09 am | News | Comments

The FBI has requested a DNA sample from "Unabomber" Ted Kaczynski as part of its investigation into the 1982 deaths of seven Chicago-area people who took cyanide-laced Tylenol from packages that had been tampered with, officials said.


BLT Mice A Better Model of HIV Transmission

May 19, 2011 11:05 am | News | Comments

A new study further validates the use of humanized BLT mice in the fight to block HIV transmission. Humanized BLT mice have a fully functioning human immune system and can be infected with HIV in the same manner as humans.


New Cell Therapy to Prevent Organ Rejection

May 19, 2011 11:02 am | News | Comments

Researchers have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.


Aspirin, Simvastatin No Help in PAH

May 19, 2011 11:00 am | News | Comments

An NIH-funded study has found that despite their beneficial effects in treating heart disease, neither aspirin nor simvastatin appear to offer benefit to patients suffering from pulmonary artery hypertension.


New Treatment Beneficial in Advanced Colon Cancer

May 19, 2011 10:56 am | News | Comments

Research physicians believe that a new treatment regimen for patients with metastatic colon cancer appears to offer clinical benefit even when used after multiple other treatments have failed.


Quay Adds Equipment, GMP Compliance

May 19, 2011 10:44 am | News | Comments

Quay Pharmaceuticals has invested in a variety of new equipment as part of its move to its purpose-designed facility in Deeside, U.K., which was officially opened last year.


Pharmatek Adds Spray Drying to Development Services

May 19, 2011 10:41 am | News | Comments

Pharmatek Laboratories, Inc. has added spray drying to its drug formulation and manufacturing capabilities, purchasing a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.


ERT Awarded over $10 Million of ePRO Business

May 19, 2011 10:36 am | News | Comments

ERT has signed three contracts with pharmaceutical companies for its electronic patient reported outcomes (ePRO) business , totaling over $10 million.


DaVita Clinical Research Opens Cleanroom

May 19, 2011 10:31 am | News | Comments

DaVita Clinical Research has completed a Phase I-IIa cleanroom to comply with USP 797 high risk regulations demonstrating the cleanroom meets the requirements to handle compounds in a safe and efficient manner.


PPD Expands Product Development Consulting Services

May 19, 2011 10:27 am | News | Comments

PPD, Inc. announced it has established four practice areas through PPD Consulting-biosimilars, adaptive trial design, China regulatory strategy, and cardiovascular outcomes studies.


Ockham Appoints Vice-President of Preclinical and Regulatory Affairs

May 19, 2011 10:23 am | News | Comments

Harman Dubé has joined Ockham as vice-president of pre-clinical and regulatory affairs within the OckhamCRO division.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.